Literature DB >> 29852451

Whole blood n-3 fatty acids are associated with executive function in 2-6-year-old Northern Ghanaian children.

Mary Adjepong1, William Yakah1, William S Harris2, Reginald A Annan3, Matthew B Pontifex4, Jenifer I Fenton5.   

Abstract

Several studies demonstrate the importance of essential fatty acids (EFAs), and the long chain polyunsaturated FA docosahexaenoic acid (DHA), on cognition and brain development. The objective of this study was to investigate the relationship between whole-blood FAs and executive function in children from Northern Ghana. A total of 307, 2-to-6-year-old children attempted the dimensional change card sort (DCCS) task to assess executive function, and dried blood spot samples were collected and analyzed for FA content. Significant differences in mean % total whole-blood fatty acids were observed between children who could not follow directions on the DCCS test (49.8% of the sample) and those who could (50.2% of the sample). Positive associations with DCCS performance were observed for DHA (β=0.25, P=.06), total n-3 (β=0.17, P=.06) and dihomo-gamma-linolenic acid (DGLA; β=0.60, P=.06). Children with the highest levels of total n-3 and DHA were three and four times, respectively, more likely to pass at least one condition of the DCCS test of executive function than those with the lowest DHA levels. The results of this study indicate an association between n-3 FAs and high-level cognitive processes in children two to six years of age, providing impetus for further studies into possible interventions to improve EFA status of children in developing countries.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognition; DCCS; Essential fatty acids; Executive function; Fatty acids; Ghana; Lipids

Mesh:

Substances:

Year:  2018        PMID: 29852451     DOI: 10.1016/j.jnutbio.2018.03.019

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  7 in total

1.  No effect of 6-month supplementation with 300 mg/d docosahexaenoic acid on executive functions among healthy school-aged children: a randomized, double-blind, placebo-controlled trial.

Authors:  Ting Wu; Guo-Yi Yang; Si-Yu Huang; Bi-Xia Huang; Hai-Lin Wang; Qiu-Ye Lan; Chun-Lei Li; Hui-Lian Zhu; Ai-Ping Fang
Journal:  Eur J Nutr       Date:  2020-09-26       Impact factor: 5.614

2.  Nutrition and the developing brain.

Authors:  Christina J Valentine
Journal:  Pediatr Res       Date:  2019-10-31       Impact factor: 3.756

3.  Longitudinal investigation of the relationship between omega-3 polyunsaturated fatty acids and neuropsychological functioning in recent-onset psychosis: A randomized clinical trial.

Authors:  Philip R Szeszko; Robert K McNamara; Juan A Gallego; Anil K Malhotra; Usha Govindarajulu; Bart D Peters; Delbert G Robinson
Journal:  Schizophr Res       Date:  2021-01-11       Impact factor: 4.939

4.  Breastfeeding Duration Is Associated With Domain-Specific Improvements in Cognitive Performance in 9-10-Year-Old Children.

Authors:  Daniel A Lopez; John J Foxe; Yunjiao Mao; Wesley K Thompson; Hayley J Martin; Edward G Freedman
Journal:  Front Public Health       Date:  2021-04-26

Review 5.  Nutritional Support of Neurodevelopment and Cognitive Function in Infants and Young Children-An Update and Novel Insights.

Authors:  Kathrin Cohen Kadosh; Leilani Muhardi; Panam Parikh; Melissa Basso; Hamid Jan Jan Mohamed; Titis Prawitasari; Folake Samuel; Guansheng Ma; Jan Mw Geurts
Journal:  Nutrients       Date:  2021-01-10       Impact factor: 5.717

6.  Association of Whole Blood Fatty Acids and Growth in Southern Ghanaian Children 2⁻6 Years of Age.

Authors:  Mary Adjepong; William Yakah; William S Harris; Esi Colecraft; Grace S Marquis; Jenifer I Fenton
Journal:  Nutrients       Date:  2018-07-24       Impact factor: 5.717

Review 7.  Importance of EPA and DHA Blood Levels in Brain Structure and Function.

Authors:  Clemens von Schacky
Journal:  Nutrients       Date:  2021-03-25       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.